Joel Greenblatt Dynavax Technologies Corp Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 20,215 shares of DVAX stock, worth $246,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,215

Previous 36,440 44.53%

Holding current value

$246,016

Previous $409,000 44.99%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.05 - $11.61 $163,061 - $188,372	-16,225 Reduced 44.53%	20,215 $225,000
Q2 2024 Aug 14, 2024	SELL	$10.73 - $12.58 $369,251 - $432,915	-34,413 Reduced 48.57%	36,440 $409,000
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $209,102 - $267,722	17,872 Added 33.73%	70,853 $879,000
Q4 2023 Feb 14, 2024	SELL	$13.09 - $14.98 $15,459 - $17,691	-1,181 Reduced 2.18%	52,981 $740,000
Q3 2023 Nov 14, 2023	SELL	$12.64 - $14.99 $6,699 - $7,944	-530 Reduced 0.97%	54,162 $799,000
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $770,506 - $1.03 Million	-78,224 Reduced 58.85%	54,692 $706,000
Q1 2023 May 15, 2023	SELL	$9.44 - $11.88 $1.03 Million - $1.3 Million	-109,472 Reduced 45.16%	132,916 $1.3 Million
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $759,733 - $983,141	73,976 Added 43.93%	242,388 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $1.09 Million - $1.92 Million	109,810 Added 187.38%	168,412 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $219,991 - $378,857	-29,529 Reduced 33.51%	58,602 $738,000
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $442,094 - $654,752	45,343 Added 105.97%	88,131 $955,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $108,046 - $171,791	-8,204 Reduced 16.09%	42,788 $602,000
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $467,086 - $1.01 Million	50,992 New	50,992 $980,000

Others Institutions Holding DVAX

# of Institutions

274

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account